Steroid-Induced Rosacea in Systemic Lupus Erythematosus

A 59-year-old female with systemic lupus erythematosus developed rosacea after prolonged use of topical corticosteroids, which initially cleared lesions but eventually led to skin atrophy and rosacea symptoms. Her condition improved after switching to topical metronidazole, nicotinamide, and tretinoin, and discontinuing corticosteroids. This case highlighted the challenge of diagnosing rosacea, especially when it mimics other conditions like lupus, and emphasized the need for careful consideration before long-term corticosteroid use due to potential adverse effects like steroid-induced rosacea.